100 ML eptifibatide 0.75 MG/ML Injection
- RxCUI
- 200349
- RxNorm name
- 100 ML eptifibatide 0.75 MG/ML Injection
- Display name
- 100 ML eptifibatide 0.75 MG/ML Injection
- Full name
- 100 ML eptifibatide 0.75 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eptifibatide | EPTIFIBATIDE | Slate Run Pharmaceuticals, LLC | da421d88-6c00-428a-82a6-b3b4f7a68b85 | 2026-02-09 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Slate Run Pharmaceuticals, LLC | 2ab98ecd-c578-4032-a3d5-ae14d58d86a7 | 2026-02-09 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | c488f1af-a82c-4360-8886-79520635561a | 2025-10-20 | Warnings | 200349 |
| Eptifibatide | EPTIFIBATIDE | Avenacy, LLC | c0781dae-3ef6-4cab-b084-01d2e45f3764 | 2024-08-15 | Warnings, Adverse reactions | 200349 |
| eptifibatide | EPTIFIBATIDE | Sagent Pharmaceuticals | a0d18778-0194-461a-a4ea-b2fca5df57c3 | 2024-08-15 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Baxter Healthcare Company | 5f46b76b-5c83-49b9-ada8-4ad5cf81a38c | 2024-05-29 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Meitheal Pharmaceuticals Inc. | 3e7e7cd3-8efa-4d91-a5ab-7fd78b0cc65e | 2024-05-14 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Eugia US LLC | 00ad7bbe-cadd-4647-b74b-adfc9f2b5e94 | 2024-01-04 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Mylan Institutional LLC | a7a89c59-22fb-41fd-b70a-ac2395717db1 | 2021-05-28 | Warnings, Adverse reactions | 200349 |
| Eptifibatide | EPTIFIBATIDE | Mylan Institutional LLC | 88a37f9c-496b-4a6b-9665-4550abba04f1 | 2021-05-28 | Warnings, Adverse reactions | 200349 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5f46b76b-5c83-49b9-ada8-4ad5cf81a38c | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 13 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous infusion only; not for intravenous bolus use Initial U.S. Approval: 1998 | 20240529 |
| c488f1af-a82c-4360-8886-79520635561a | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 9 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20251020 |
| 3e7e7cd3-8efa-4d91-a5ab-7fd78b0cc65e | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 8 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20240514 |
| 00ad7bbe-cadd-4647-b74b-adfc9f2b5e94 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20240104 |
| 2ab98ecd-c578-4032-a3d5-ae14d58d86a7 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20260209 |
| da421d88-6c00-428a-82a6-b3b4f7a68b85 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20260209 |
| a0d18778-0194-461a-a4ea-b2fca5df57c3 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use EPTIFIBATIDE injection safely and effectively. See full prescribing information for EPTIFIBATIDE injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20240815 |
| 88a37f9c-496b-4a6b-9665-4550abba04f1 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20210528 |
| a7a89c59-22fb-41fd-b70a-ac2395717db1 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20210528 |
| c0781dae-3ef6-4cab-b084-01d2e45f3764 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20240815 |
| 80b86c46-230c-0090-e053-2991aa0a8fc1 | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998 | 20210427 |
| ef0ad483-9086-4267-9b57-fcedd868719c | eptifibatide 75 MG in 100 ML Injection [PSN] · 100 ML eptifibatide 0.75 MG/ML Injection [SCD] · eptifibatide 75 MG per 100 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use Eptifibatide Injection safely and effectively. See full prescribing information for Eptifibatide Injection. Eptifibatide Injection, for intravenous use Initial U.S. Approval: 1998 | 20190326 |